Russell Investments Group’s Centessa Pharmaceuticals CNTA Stock Holding History

Russell Investments Group’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-38,812	Closed	-$1.54M	–	4389
2026 Q1	$1.54M	Sell	38,812 -36,007	-48%	-$921K	﹤0.01%	1997
2025 Q4	$1.87M	Sell	74,819 -107,481	-59%	-$2.72M	﹤0.01%	1905
2025 Q3	$4.42M	Buy	182,300 +41,335	+29%	+$735K	0.01%	1385
2025 Q2	$1.85M	Sell	140,965 -86,633	-38%	-$1.1M	﹤0.01%	1758
2025 Q1	$3.27M	Buy	+227,598	New	+$3.72M	﹤0.01%	1424

Russell Investments Group's CNTA Position: Q2 2026 in Review

Russell Investments Group sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 38,812 shares — an estimated $1.54M sold.

Russell Investments Group first reported a position in CNTA in Q1 2025 and held it in 5 quarters. The position peaked at $4.42M in Q3 2025. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Russell Investments Group reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Russell Investments Group sold 38,812 Centessa Pharmaceuticals shares in Q2 2026, an estimated $1.54M.
Russell Investments Group first reported a position in Centessa Pharmaceuticals in Q1 2025 and held it in 5 quarters.
Russell Investments Group's Centessa Pharmaceuticals position peaked at $4.42M in Q3 2025.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.